Skip to content
Riskpilot
← Back to search
Sign in
Get full access
STX PHARMACEUTICALS ApS
APS
Bankrupt
Advertising protection
CVR 25836812
Kvæsthusgade 5C, 1251
København K
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
·
NACE 721900
Est. 2001 · 25 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
/
STX PHARMACEUTICALS ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (6)
KH
Kjeld Hermansen
Management
Management
2001 – 2005
SS
Søren Stenderup
Chief Executive Officer
Chief Executive Officer
2013 – 2014
MF
Michael Fræmohs
Audit
Audit
2001 – 2005
KM
Kim Madsen
Management
Management
2001 – 2001
PB
Per Bendix Jeppesen
Management
Management
2012 – 2013
NV
Niels Vesth
Chief Executive Officer
Chief Executive Officer
2005 – 2012
Board of directors
Non-executive oversight
Name
Role
Member since
Former (5)
OB
Ole Bitsch-Jensen
Chairman
Chairman
2008 – 2012
PA
Peter Andreas Stakemann
Board of Directors
Board of Directors
2001 – 2001
SG
Søren Gregersen
Board of Directors
Board of Directors
2001 – 2005
PJ
Philip Just Larsen
Chairman
Chairman
2005 – 2008
KS
Katrine Steen
Chairman
Chairman
2012 – 2013
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on STX PHARMACEUTICALS ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network